Mesenchymal Stem Cells

The results of a new human trial suggest that mesenchymal stem cell therapy may represent an effective means to treat the inflammation associated with sepsis

New study highlights the exciting potential for autologous micro‐fragmented adipose tissue in the treatment of osteoarthritis in patients following an animal trial

Analyses of mesenchymal stem cells derived from MS patients suggests that lowered stress responses may inhibit therapeutic outcomes

Researchers discover that the overexpression of an Angiotensin II receptor in MSCs improves their migration to the injured lung and improves therapeutic effect

Researchers establish that clinically relevant adult stem cell populations promote clot formation via the varying expression of the tissue factor clotting component

Researchers report that resveratrol can reverse inflammation-mediated effects, promote cell aggregation, and enhance stem cell-mediated periodontal repair

The site of origin of mesenchymal stem cells and their inherent adhesive capabilities may significantly influence their therapeutic application

New research suggests that a combination of MSCs and ATRA treatment in the presence of p70S6k1 signaling can enhance lung repair in a mouse emphysema model

New research suggests that MSCs derived from induced pluripotent stem cells are as effective as adipose-derived MSCs in treating inflammatory bowel disease in mice

New research suggests that potentiating the AKT-mTOR signaling axis can boost tenogenesis of mesenchymal stem cells and improve current tendon repair strategies